Scaini, G., de Quevedo, J. L., Velligan, D. I., Roberts, D. L., Raventós Vorst, H., & Walss Bass, C. (2018). Second generation antipsychotic-induced mitochondrial alterations: Implications for increased risk of metabolic syndrome in patients with schizophrenia.

Scaini, Giselli, João Luciano de Quevedo, Dawn I. Velligan, David Leland Roberts, Henriette Raventós Vorst, y Consuelo Walss Bass. Second Generation Antipsychotic-induced Mitochondrial Alterations: Implications for Increased Risk of Metabolic Syndrome in Patients With Schizophrenia. 2018.

Scaini, Giselli, et al. Second Generation Antipsychotic-induced Mitochondrial Alterations: Implications for Increased Risk of Metabolic Syndrome in Patients With Schizophrenia. 2018.